Literature DB >> 21529730

Usefulness of combined assessment with computed tomographic signs of right ventricular dysfunction and cardiac troponin T for risk stratification of acute pulmonary embolism.

Doo Kyoung Kang1, Joo Sung Sun, Kyung Joo Park, Hong Seok Lim.   

Abstract

The aim of this study was to evaluate the incremental value of combined assessment with computed tomographic (CT) signs of right ventricular (RV) dysfunction and cardiac troponin T level for predicting early death or adverse outcomes due to acute pulmonary embolism (PE). One hundred seventy-three non-high-risk patients with acute PE, confirmed by CT pulmonary angiography, were retrospectively evaluated. The area under the curve and hazard ratio of CT signs and troponin T levels were compared for predicting early death or adverse outcomes. Patients were classified into intermediate- and low-risk groups on the basis of CT signs and troponin T levels, and mortality was compared. Seventeen patients (9.8%) died within 3 months. Early mortality of intermediate-risk patients (14% to 19%) was higher than that of low-risk patents (2% to 6%). A ratio of RV volume to left ventricular volume > 1.5 had the highest area under the curve (0.709) and hazard ratio (5.402) for predicting early death. The combination of CT signs and elevated troponin T level had an increased area under the curve and hazard ratio for predicting early death and adverse outcomes compared to those of CT signs or elevated troponin T level alone. In conclusion, the combined assessment of the ratio of RV volume to left ventricular volume and an elevated troponin T level provided incrementally more prognostic information in non-high-risk patients with acute PE compared to the single predictor of CT signs or troponin T level.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529730     DOI: 10.1016/j.amjcard.2011.03.009

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Prognostic Value of Biomarkers in Acute Non-massive Pulmonary Embolism: A Systematic Review and Meta-analysis.

Authors:  Anurag Bajaj; Parul Rathor; Vishal Sehgal; Besher Kabak; Ajay Shetty; Ossama Al Masalmeh; Srikanth Hosur
Journal:  Lung       Date:  2015-07-02       Impact factor: 2.584

2.  Septal bowing and pulmonary artery diameter on computed tomography pulmonary angiography are associated with short-term outcomes in patients with acute pulmonary embolism.

Authors:  Mads Dam Lyhne; Jacob Gammelgaard Schultz; Peter J MacMahon; Faris Haddad; Mannudeep Kalra; David Mai-King Tso; Alona Muzikansky; Michael H Lev; Christopher Kabrhel
Journal:  Emerg Radiol       Date:  2019-08-02

3.  Implications of elevated cardiac troponin in patients presenting with acute pulmonary embolism: an observational study.

Authors:  Ayman El-Menyar; Mohammad Asim; Syed Nabir; Mohamed Nadeem Ahmed; Hassan Al-Thani
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 4.  Hemodynamic indexes derived from computed tomography angiography to predict pulmonary embolism related mortality.

Authors:  Gregor John; Christophe Marti; Pierre-Alexandre Poletti; Arnaud Perrier
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

5.  Accuracy and reproducibility of CT right-to-left ventricular diameter measurement in patients with acute pulmonary embolism.

Authors:  Yvonne M Ende-Verhaar; Lucia J M Kroft; Inge C M Mos; Menno V Huisman; Frederikus A Klok
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

6.  The Ratio of Descending Aortic Enhancement to Main Pulmonary Artery Enhancement Measured on Pulmonary CT Angiography as a Finding to Predict Poor Outcome in Patients with Massive or Submassive Pulmonary Embolism.

Authors:  Chi Young Park; Seung Min Yoo; Ji Young Rho; Young Geon Ji; Hwa Yeon Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-04-30

7.  Benefit of early discharge among patients with low-risk pulmonary embolism.

Authors:  Li Wang; Onur Baser; Phil Wells; W Frank Peacock; Craig I Coleman; Gregory J Fermann; Jeff Schein; Concetta Crivera
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.